Figure 5From: Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts Operational costs per person by vaccine and strength of the routine immunization program (using DTP3 or MCV1 as a proxy for program strength), 2004–2011 – Analysis of cMYP data. Back to article page